Your browser doesn't support javascript.
loading
Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation.
Sanders, Jes M; Jeyamogan, Shareni; Mathew, James M; Leventhal, Joseph R.
Afiliación
  • Sanders JM; Department of Surgery, Comprehensive Transplant Center Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Jeyamogan S; Department of Surgery, Comprehensive Transplant Center Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Mathew JM; Department of Surgery, Comprehensive Transplant Center Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Leventhal JR; Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
Front Immunol ; 13: 1055466, 2022.
Article en En | MEDLINE | ID: mdl-36466912
ABSTRACT
Regulatory T cells (Tregs) are critical for tolerance in humans. The exact mechanisms by which the loss of peripheral tolerance leads to the development of autoimmunity and the specific role Tregs play in allograft tolerance are not fully understood; however, this population of T cells presents a unique opportunity in the development of targeted therapeutics. In this review, we discuss the potential roles of Foxp3+ Tregs in the development of tolerance in transplantation and autoimmunity, and the available data regarding their use as a treatment modality.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoinmunidad / Trasplante de Órganos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoinmunidad / Trasplante de Órganos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article